Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
ImmunoGen participates in a conference call with JPMorgan » 09:57
06/09/21
06/09
09:57
06/09/21
09:57
IMGN

ImmunoGen

$6.40 /

+0.12 (+1.91%)

Conference call with CEO…

Conference call with CEO Enyedy, CFO Altschuller and CMO Berkenblit will be held on June 9 at 11 am hosted by JPMorgan.

ShowHide Related Items >><<
IMGN ImmunoGen
$6.40 /

+0.12 (+1.91%)

06/07/21 Piper Sandler
ImmunoGen data largely consistent with prior updates, says Piper Sandler
05/10/21 Piper Sandler
Piper says ImmunoGen's 'modest' timeline slip makes cash runway 'more tenuous'
02/16/21 H.C. Wainwright
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright
12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
IMGN ImmunoGen
$6.40 /

+0.12 (+1.91%)

IMGN ImmunoGen
$6.40 /

+0.12 (+1.91%)

Recommendations
ImmunoGen data largely consistent with prior updates, says Piper Sandler » 11:36
06/07/21
06/07
11:36
06/07/21
11:36
IMGN

ImmunoGen

$6.08 /

+0.29 (+5.01%)

ImmunoGen presented…

ImmunoGen presented updated data from the Phase II FORWARD II trial evaluating mirvetuximab in combination with bevacizumab in patients with r/r ovarian cancer that were largely consistent with prior updates with FRalpha-high patients demonstrating notable response rates and durability, Piper Sandler analyst Joseph Catanzaro tells investors in a research note. Catanzaro, who made no change to his Neutral rating, says that while he continues to view mirve monotherapy as having a high chance of success in late-line FRa-high PROC via SORAYA and MIRASOL, he seeks greater visibility into how these combination data can be leveraged into a future commercial opportunity and whether compendia listing is a viable path and sufficient to drive meaningful adoption.

ShowHide Related Items >><<
IMGN ImmunoGen
$6.08 /

+0.29 (+5.01%)

05/10/21 Piper Sandler
Piper says ImmunoGen's 'modest' timeline slip makes cash runway 'more tenuous'
02/16/21 H.C. Wainwright
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright
12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
IMGN ImmunoGen
$6.08 /

+0.29 (+5.01%)

IMGN ImmunoGen
$6.08 /

+0.29 (+5.01%)

Over a month ago
Recommendations
Piper says ImmunoGen's 'modest' timeline slip makes cash runway 'more tenuous' » 10:53
05/10/21
05/10
10:53
05/10/21
10:53
IMGN

ImmunoGen

$6.80 /

-0.53 (-7.23%)

After ImmunoGen reported…

After ImmunoGen reported Q1 results and said that timelines around mirvetuximab's pivotal and confirmatory studies in platinum-resistant ovarian cancer have been pushed slightly out due to a COVID-related enrollment slowdown, Piper Sandler analyst Joseph Catanzaro said the "modest slip" in timelines makes the company's current cash runway "perhaps a bit more tenuous." While he said he continues to "take a glass half full" view, Catanzaro keeps a Neutral rating and $6.50 price target on ImmunoGen shares.

ShowHide Related Items >><<
IMGN ImmunoGen
$6.80 /

-0.53 (-7.23%)

IMGN ImmunoGen
$6.80 /

-0.53 (-7.23%)

02/16/21 H.C. Wainwright
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright
12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
IMGN ImmunoGen
$6.80 /

-0.53 (-7.23%)

IMGN ImmunoGen
$6.80 /

-0.53 (-7.23%)

On The Fly
Fly Intel: Pre-market Movers » 09:04
05/10/21
05/10
09:04
05/10/21
09:04
FEYE

FireEye

$19.31 /

+0.23 (+1.21%)

, BNTX

BioNTech

$183.73 /

+15.69 (+9.34%)

, J

Jacobs

$140.04 /

+1.49 (+1.08%)

, ENR

Energizer

$50.57 /

+1.215 (+2.46%)

, PRTY

Party City

$7.95 /

-0.05 (-0.63%)

, WB

Weibo

$48.00 /

-0.01 (-0.02%)

, MX

MagnaChip

$24.20 /

+0.16 (+0.67%)

, MTNB

Matinas BioPharma

/

+

, APD

Air Products

$290.70 /

-2.78 (-0.95%)

, MAR

Marriott

$146.59 /

+4.01 (+2.81%)

, COTY

Coty

$10.35 /

+0.35 (+3.50%)

, IMGN

ImmunoGen

$7.33 /

+0.275 (+3.90%)

, KOS

Kosmos

$3.14 /

+0.22 (+7.53%)

, CCO

Clear Channel Outdoor

$2.56 /

+0.09 (+3.64%)

, GLPG

Galapagos

$75.04 /

-1.09 (-1.43%)

Check out this morning's…

ShowHide Related Items >><<
WB Weibo
$48.00 /

-0.01 (-0.02%)

PRTY Party City
$7.95 /

-0.05 (-0.63%)

MX MagnaChip
$24.20 /

+0.16 (+0.67%)

MTNB Matinas BioPharma
/

+

MAR Marriott
$146.59 /

+4.01 (+2.81%)

KOS Kosmos
$3.14 /

+0.22 (+7.53%)

J Jacobs
$140.04 /

+1.49 (+1.08%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

GLPG Galapagos
$75.04 /

-1.09 (-1.43%)

FEYE FireEye
$19.31 /

+0.23 (+1.21%)

ENR Energizer
$50.57 /

+1.215 (+2.46%)

COTY Coty
$10.35 /

+0.35 (+3.50%)

CCO Clear Channel Outdoor
$2.56 /

+0.09 (+3.64%)

BNTX BioNTech
$183.73 /

+15.69 (+9.34%)

APD Air Products
$290.70 /

-2.78 (-0.95%)

FEYE FireEye
$19.31 /

+0.23 (+1.21%)

02/04/21
Fly Intel: Top five analyst upgrades
02/04/21 BofA
FireEye upgraded to Buy on 'solid execution' at BofA
02/04/21 BofA
FireEye upgraded to Buy from Neutral at BofA
02/03/21
FireEye price target raised to $25 from $17 at BMO Capital
BNTX BioNTech
$183.73 /

+15.69 (+9.34%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
J Jacobs
$140.04 /

+1.49 (+1.08%)

04/21/21 Citi
Jacobs Engineering price target raised to $156 from $129 at Citi
04/19/21 Stifel
Jacobs Engineering price target raised to $170 from $128 at Stifel
04/19/21 Stifel
Parsons added to Stifel Select List, price target boosted to $70
03/05/21 Benchmark
Jacobs Engineering price target raised to $130 from $120 at Benchmark
ENR Energizer
$50.57 /

+1.215 (+2.46%)

05/03/21 Deutsche Bank
Energizer price target raised to $56 from $54 at Deutsche Bank
04/16/21 JPMorgan
Energizer price target raised to $52 from $51 at JPMorgan
02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Goldman Sachs
Energizer downgraded to Neutral from Buy at Goldman Sachs
PRTY Party City
$7.95 /

-0.05 (-0.63%)

12/09/20 Stephens
Party City price target raised to $5 at Stephens after sale of international ops
WB Weibo
$48.00 /

-0.01 (-0.02%)

03/19/21 Benchmark
Weibo price target raised to $67 from $50 at Benchmark
03/19/21 HSBC
Weibo price target raised to $40 from $30.60 at HSBC
12/31/20
Fly Intel: Top five analyst calls
12/31/20
Weibo downgraded to Hold from Buy at First Shanghai
MX MagnaChip
$24.20 /

+0.16 (+0.67%)

03/30/21 Vertical Group
MagnaChip downgraded to Neutral from Buy at Vertical Group
03/04/21 Needham
Needham revises view on MagnaChip SOTP value to $41-$46 per share
03/04/21 Needham
MagnaChip could be worth $39-$45 per share in a deal, says Needham
02/23/21 Citi
MagnaChip price target raised to $20 from $19 at Citi
MTNB Matinas BioPharma
/

+

03/30/21 H.C. Wainwright
Matinas BioPharma price target lowered to $3 from $4 at H.C. Wainwright
02/01/21 Piper Sandler
Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
01/04/21 Piper Sandler
Matinas BioPharma price target raised to $4 from $1.80 at Piper Sandler
08/25/20 Piper Sandler
Matinas BioPharma transferred with an Overweight at Piper Sandler
APD Air Products
$290.70 /

-2.78 (-0.95%)

05/07/21
Fly Intel: Top five analyst downgrades
05/07/21 Barclays
Air Products downgraded to Equal Weight from Overweight at Barclays
04/06/21 Wells Fargo
Air Products price target raised to $320 from $300 at Wells Fargo
03/29/21 Credit Suisse
Air Products assumed with an Outperform at Credit Suisse
MAR Marriott
$146.59 /

+4.01 (+2.81%)

02/24/21 Stifel
American Airlines price target raised to $20 from $14 at Stifel
02/22/21 Wells Fargo
Marriott price target raised to $154 from $147 at Wells Fargo
02/22/21 Wells Fargo
Wells Fargo strategist upgrades Consumer Services sector to Overweight
02/22/21 Evercore ISI
Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform
COTY Coty
$10.35 /

+0.35 (+3.50%)

04/29/21 Citi
Citi adds Coty to Focus List, raises price target to $15
04/27/21 Stifel
Coty price target raised to $10 from $6 at Stifel
04/27/21 RBC Capital
Coty price target raised to $12 from $9 at RBC Capital
04/26/21 Deutsche Bank
Coty price target raised to $9 from $8 at Deutsche Bank
IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

02/16/21 H.C. Wainwright
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright
12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
KOS Kosmos
$3.14 /

+0.22 (+7.53%)

02/24/21 Berenberg
Kosmos downgraded to Hold from Buy at Berenberg
02/23/21 Goldman Sachs
Kosmos upgraded to Buy from Neutral at Goldman Sachs
12/16/20 Renaissance Capital
Kosmos downgraded to Hold from Buy at Renaissance Capital
12/16/20 Panmure Gordon
Kosmos initiated with a Buy at Panmure Gordon
CCO Clear Channel Outdoor
$2.56 /

+0.09 (+3.64%)

02/12/21 Citi
Clear Channel Outdoor price target raised to $2.20 from $1.60 at Citi
01/26/21 Cowen
Clear Channel Outdoor price target raised to $2.50 from $1.75 at Cowen
01/05/21 Citi
Clear Channel Outdoor downgraded to Neutral from Buy at Citi
11/02/20
Fly Intel: Top five analyst initiations
GLPG Galapagos
$75.04 /

-1.09 (-1.43%)

04/20/21 Deutsche Bank
Galapagos initiated with a Buy at Deutsche Bank
04/14/21 Barclays
Galapagos upgraded to Overweight from Equal Weight at Barclays
04/12/21 UBS
Galapagos price target raised to EUR 77 from EUR 75 at UBS
03/02/21 Barclays
Galapagos price target lowered to EUR 69 from EUR 85.50 at Barclays
WB Weibo
$48.00 /

-0.01 (-0.02%)

PRTY Party City
$7.95 /

-0.05 (-0.63%)

MX MagnaChip
$24.20 /

+0.16 (+0.67%)

MTNB Matinas BioPharma
/

+

MAR Marriott
$146.59 /

+4.01 (+2.81%)

KOS Kosmos
$3.14 /

+0.22 (+7.53%)

J Jacobs
$140.04 /

+1.49 (+1.08%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

GLPG Galapagos
$75.04 /

-1.09 (-1.43%)

FEYE FireEye
$19.31 /

+0.23 (+1.21%)

ENR Energizer
$50.57 /

+1.215 (+2.46%)

COTY Coty
$10.35 /

+0.35 (+3.50%)

CCO Clear Channel Outdoor
$2.56 /

+0.09 (+3.64%)

BNTX BioNTech
$183.73 /

+15.69 (+9.34%)

APD Air Products
$290.70 /

-2.78 (-0.95%)

  • 23
    Jul
WB Weibo
$48.00 /

-0.01 (-0.02%)

MAR Marriott
$146.59 /

+4.01 (+2.81%)

J Jacobs
$140.04 /

+1.49 (+1.08%)

GLPG Galapagos
$75.04 /

-1.09 (-1.43%)

FEYE FireEye
$19.31 /

+0.23 (+1.21%)

ENR Energizer
$50.57 /

+1.215 (+2.46%)

COTY Coty
$10.35 /

+0.35 (+3.50%)

BNTX BioNTech
$183.73 /

+15.69 (+9.34%)

WB Weibo
$48.00 /

-0.01 (-0.02%)

PRTY Party City
$7.95 /

-0.05 (-0.63%)

MX MagnaChip
$24.20 /

+0.16 (+0.67%)

MTNB Matinas BioPharma
/

+

MAR Marriott
$146.59 /

+4.01 (+2.81%)

KOS Kosmos
$3.14 /

+0.22 (+7.53%)

J Jacobs
$140.04 /

+1.49 (+1.08%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

GLPG Galapagos
$75.04 /

-1.09 (-1.43%)

FEYE FireEye
$19.31 /

+0.23 (+1.21%)

ENR Energizer
$50.57 /

+1.215 (+2.46%)

COTY Coty
$10.35 /

+0.35 (+3.50%)

BNTX BioNTech
$183.73 /

+15.69 (+9.34%)

APD Air Products
$290.70 /

-2.78 (-0.95%)

WB Weibo
$48.00 /

-0.01 (-0.02%)

PRTY Party City
$7.95 /

-0.05 (-0.63%)

MAR Marriott
$146.59 /

+4.01 (+2.81%)

KOS Kosmos
$3.14 /

+0.22 (+7.53%)

FEYE FireEye
$19.31 /

+0.23 (+1.21%)

COTY Coty
$10.35 /

+0.35 (+3.50%)

BNTX BioNTech
$183.73 /

+15.69 (+9.34%)

Earnings
ImmunoGen backs FY21 revenue view $65M-$75M, consensus $70.02M » 06:33
05/10/21
05/10
06:33
05/10/21
06:33
IMGN

ImmunoGen

$7.33 /

+0.275 (+3.90%)

ImmunoGen expects that…

ImmunoGen expects that its current cash will fund operations into the second half of 2022.

ShowHide Related Items >><<
IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

02/16/21 H.C. Wainwright
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright
12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

Earnings
ImmunoGen reports Q1 EPS (17c), consensus (19c) » 06:32
05/10/21
05/10
06:32
05/10/21
06:32
IMGN

ImmunoGen

$7.33 /

+0.275 (+3.90%)

Reports Q1 revenue…

Reports Q1 revenue $15.7M, consensus $17.73M.

ShowHide Related Items >><<
IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

02/16/21 H.C. Wainwright
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright
12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

IMGN ImmunoGen
$7.33 /

+0.275 (+3.90%)

Over a quarter ago
Recommendations
ImmunoGen price target raised to $12 from $11 at H.C. Wainwright » 06:11
02/16/21
02/16
06:11
02/16/21
06:11
IMGN

ImmunoGen

$10.51 /

+2.405 (+29.67%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Swayampakula Ramakanth raised the firm's price target on ImmunoGen to $12 from $11 and reiterates a Buy rating on the shares following the company's Q4 results.

ShowHide Related Items >><<
IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:15
02/12/21
02/12
16:15
02/12/21
16:15
DIS

Disney

$187.69 /

-3.27 (-1.71%)

, EXPE

Expedia

$146.49 /

-3.13 (-2.09%)

, IIVI

II-VI

$89.82 /

-9.81 (-9.85%)

, COHR

Coherent

$257.89 /

+31.66 (+13.99%)

, LITE

Lumentum

$94.00 /

+1.41 (+1.52%)

, MKSI

MKS Instruments

$167.45 /

+5.23 (+3.22%)

, MRNA

Moderna

$183.60 /

+0.18 (+0.10%)

, PFE

Pfizer

$34.72 /

+0.29 (+0.84%)

, GOOG

Alphabet

$2,104.55 /

+8.99 (+0.43%)

, GOOGL

Alphabet Class A

$2,095.83 /

+6.23 (+0.30%)

, MSFT

Microsoft

$244.99 /

+0.6 (+0.25%)

, QCOM

Qualcomm

$147.98 /

+2.53 (+1.74%)

, NVDA

Nvidia

$598.42 /

-11.89 (-1.95%)

, XERS

Xeris Pharmaceuticals

$6.84 /

+0.22 (+3.32%)

, IMGN

ImmunoGen

$10.51 /

+2.405 (+29.67%)

, HUBS

HubSpot

$501.62 /

+69.38 (+16.05%)

, FOLD

Amicus

$12.56 /

-6.2 (-33.05%)

, LLNW

Limelight Networks

$3.96 /

-0.6 (-13.16%)

, NWL

Newell Brands

$24.19 /

-1.85 (-7.10%)

The major averages closed…

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

MKSI MKS Instruments
$167.45 /

+5.23 (+3.22%)

LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

02/12/21 Loop Capital
Disney price target raised to $230 from $190 at Loop Capital
02/12/21 Evercore ISI
Disney price target raised to $210 from $200 at Evercore ISI
02/12/21 JPMorgan
Disney price target raised to $220 from $210 at JPMorgan
02/12/21 Credit Suisse
Disney price target raised to $218 from $192 at Credit Suisse
EXPE Expedia
$146.49 /

-3.13 (-2.09%)

02/12/21 Stifel
Expedia price target raised to $140 from $117 at Stifel
02/12/21 Cowen
Expedia price target raised to $150 from $140 at Cowen
02/12/21 Benchmark
Expedia price target raised to $175 from $120 at Benchmark
02/12/21 Barclays
Expedia price target raised to $167 from $140 at Barclays
IIVI II-VI
$89.82 /

-9.81 (-9.85%)

02/12/21 Benchmark
Benchmark maintains Buy rating on II-VI after Coherent bid
02/10/21 DA Davidson
II-VI price target raised to $115 from $60 at DA Davidson
02/10/21 Cowen
II-VI price target raised to $124 from $86 at Cowen
02/10/21 Canaccord
II-VI price target raised to $152 from $86 at Canaccord
COHR Coherent
$257.89 /

+31.66 (+13.99%)

02/11/21 Benchmark
Coherent downgraded to Hold from Buy at Benchmark
02/08/21 Stifel
Coherent bid may force Lumentum to raise offer, says Stifel
02/08/21 Benchmark
Coherent deal with MKS could face regulators' scrutiny, says Benchmark
LITE Lumentum
$94.00 /

+1.41 (+1.52%)

MKSI MKS Instruments
$167.45 /

+5.23 (+3.22%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

02/03/21 Piper Sandler
Moderna's vaccine approved in Singapore, says Piper Sandler
02/01/21
Fly Intel: Top five analyst downgrades
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Oppenheimer
Moderna price target raised to $206 from $178 at Oppenheimer
PFE Pfizer
$34.72 /

+0.29 (+0.84%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
02/03/21 Mizuho
Pfizer price target lowered to $42 from $44 at Mizuho
GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

02/12/21 Citi
Citi boosts Alphabet target but shares no longer a top pick
02/08/21 Stephens
Global Payments merchant business advanced by Google pact, says Stephens
02/03/21 JMP Securities
Alphabet price target raised to $2,400 from $1,700 at JMP Securities
02/03/21 JPMorgan
Alphabet price target raised to $2,390 from $2,050 at JPMorgan
GOOGL Alphabet Class A
$2,095.83 /

+6.23 (+0.30%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

02/08/21 KeyBanc
Viva reinforces Microsoft Office/Teams innovation commitment, says KeyBanc
02/08/21 RBC Capital
Datadog price target raised to $110 from $85 at RBC Capital
02/03/21 Wedbush
Cloud arms race hitting another gear with Amazon CEO move, says Wedbush
02/03/21 Jefferies
Alphabet price target raised to $2,400 from $2,150 at Jefferies
QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

02/10/21 JPMorgan
China mobile shipments data point to 'robust' Apple demand, says JPMorgan
02/08/21 JPMorgan
JPMorgan prefers shares of Qualcomm over Apple
02/04/21
Fly Intel: Top five analyst downgrades
02/04/21
Qualcomm price target raised to $150 from $126 at RBC Capital
NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

02/03/21 New Street
Nvidia upgraded to Neutral from Reduce at New Street
01/26/21 Barclays
Nvidia price target raised to $600 from $550 at Barclays
01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/15/21 Truist
Nvidia price target raised to $672 from $643 at Truist
XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

02/12/21 Needham
HubSpot price target raised to $520 from $400 at Needham
02/12/21 Cowen
HubSpot price target raised to $510 from $400 at Cowen
02/12/21 Raymond James
HubSpot upgraded to Strong Buy from Outperform at Raymond James
02/12/21 Truist
HubSpot price target raised to $600 from $455 at Truist
FOLD Amicus
$12.56 /

-6.2 (-33.05%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
NWL Newell Brands
$24.19 /

-1.85 (-7.10%)

02/04/21 Deutsche Bank
Newell Brands price target raised to $23 from $18 at Deutsche Bank
01/08/21 BofA
Newell Brands upgraded to Buy on shift away from home at BofA
01/08/21 BofA
Newell Brands upgraded to Buy from Neutral at BofA
01/04/21 Jefferies
Jefferies upgrades 'underappreciated' Newell Brands to Buy from Hold
XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NWL Newell Brands
$24.19 /

-1.85 (-7.10%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

MKSI MKS Instruments
$167.45 /

+5.23 (+3.22%)

LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

GOOGL Alphabet Class A
$2,095.83 /

+6.23 (+0.30%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

  • 02
    Jul
  • 26
    Jun
  • 19
    May
QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NWL Newell Brands
$24.19 /

-1.85 (-7.10%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

GOOGL Alphabet Class A
$2,095.83 /

+6.23 (+0.30%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:09
02/12/21
02/12
12:09
02/12/21
12:09
XERS

Xeris Pharmaceuticals

$7.08 /

+0.46 (+6.95%)

, DIS

Disney

$189.57 /

-1.39 (-0.73%)

, EXPE

Expedia

$146.81 /

-2.81 (-1.88%)

, IIVI

II-VI

$93.24 /

-6.39 (-6.41%)

, COHR

Coherent

$259.58 /

+33.35 (+14.74%)

, LITE

Lumentum

$94.62 /

+2.03 (+2.19%)

, MKSI

MKS Instruments

$167.71 /

+5.49 (+3.38%)

, MRNA

Moderna

$180.40 /

-3.02 (-1.65%)

, PFE

Pfizer

$34.85 /

+0.42 (+1.22%)

, IMGN

ImmunoGen

$10.56 /

+2.455 (+30.29%)

, HUBS

HubSpot

$503.52 /

+71.28 (+16.49%)

, FOLD

Amicus

$12.73 /

-6.03 (-32.14%)

, LLNW

Limelight Networks

$3.58 /

-0.98 (-21.49%)

, NWL

Newell Brands

$24.15 /

-1.89 (-7.26%)

The major averages are…

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
DIS Disney
$189.57 /

-1.39 (-0.73%)

02/12/21 Loop Capital
Disney price target raised to $230 from $190 at Loop Capital
02/12/21 Evercore ISI
Disney price target raised to $210 from $200 at Evercore ISI
02/12/21 JPMorgan
Disney price target raised to $220 from $210 at JPMorgan
02/12/21 Credit Suisse
Disney price target raised to $218 from $192 at Credit Suisse
EXPE Expedia
$146.81 /

-2.81 (-1.88%)

02/12/21 Stifel
Expedia price target raised to $140 from $117 at Stifel
02/12/21 Cowen
Expedia price target raised to $150 from $140 at Cowen
02/12/21 Benchmark
Expedia price target raised to $175 from $120 at Benchmark
02/12/21 Barclays
Expedia price target raised to $167 from $140 at Barclays
IIVI II-VI
$93.24 /

-6.39 (-6.41%)

02/12/21 Benchmark
Benchmark maintains Buy rating on II-VI after Coherent bid
02/10/21 DA Davidson
II-VI price target raised to $115 from $60 at DA Davidson
02/10/21 Cowen
II-VI price target raised to $124 from $86 at Cowen
02/10/21 Canaccord
II-VI price target raised to $152 from $86 at Canaccord
COHR Coherent
$259.58 /

+33.35 (+14.74%)

02/11/21 Benchmark
Coherent downgraded to Hold from Buy at Benchmark
02/08/21 Stifel
Coherent bid may force Lumentum to raise offer, says Stifel
02/08/21 Benchmark
Coherent deal with MKS could face regulators' scrutiny, says Benchmark
LITE Lumentum
$94.62 /

+2.03 (+2.19%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

02/03/21 Piper Sandler
Moderna's vaccine approved in Singapore, says Piper Sandler
02/01/21
Fly Intel: Top five analyst downgrades
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Oppenheimer
Moderna price target raised to $206 from $178 at Oppenheimer
PFE Pfizer
$34.85 /

+0.42 (+1.22%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
02/03/21 Mizuho
Pfizer price target lowered to $42 from $44 at Mizuho
IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

02/12/21 Needham
HubSpot price target raised to $520 from $400 at Needham
02/12/21 Cowen
HubSpot price target raised to $510 from $400 at Cowen
02/12/21 Raymond James
HubSpot upgraded to Strong Buy from Outperform at Raymond James
02/12/21 Truist
HubSpot price target raised to $600 from $455 at Truist
FOLD Amicus
$12.73 /

-6.03 (-32.14%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

02/04/21 Deutsche Bank
Newell Brands price target raised to $23 from $18 at Deutsche Bank
01/08/21 BofA
Newell Brands upgraded to Buy on shift away from home at BofA
01/08/21 BofA
Newell Brands upgraded to Buy from Neutral at BofA
01/04/21 Jefferies
Jefferies upgrades 'underappreciated' Newell Brands to Buy from Hold
XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

  • 02
    Jul
  • 26
    Jun
  • 19
    May
PFE Pfizer
$34.85 /

+0.42 (+1.22%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

Earnings
ImmunoGen sees 2021 revenue $65M-$75M, consensus $53.12M » 06:35
02/12/21
02/12
06:35
02/12/21
06:35
IMGN

ImmunoGen

$8.10 /

+0.13 (+1.63%)

Sees current cash…

Sees current cash sufficient to fund operations into second half of 2022.

ShowHide Related Items >><<
IMGN ImmunoGen
$8.10 /

+0.13 (+1.63%)

IMGN ImmunoGen
$8.10 /

+0.13 (+1.63%)

12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
IMGN ImmunoGen
$8.10 /

+0.13 (+1.63%)

IMGN ImmunoGen
$8.10 /

+0.13 (+1.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.